Leadership Overview
AstraZeneca has 10 executives leading key functions including finance, operations, and strategy.
Driven by scientific innovation, AstraZeneca is dedicated to pushing the boundaries of medicine to deliver life-changing treatments in oncology and biopharmaceuticals, impacting global health outcomes.
Driven by scientific innovation, AstraZeneca is dedicated to pushing the boundaries of medicine to deliver life-changing treatments in oncology and biopharmaceuticals, impacting global health outcomes.
Leadership Roles at AstraZeneca
Priscila Plaza - Chief Financial Officer
Priscila Plaza, the Chief Financial Officer at AstraZeneca, directs financial strategy and oversight for the company's global operations. This leadership role involves managing all aspects of financial planning, analysis, and reporting, ensuring fiscal responsibility across the organization. Plaza's responsibilities extend to optimizing capital allocation and driving financial performance in alignment with AstraZeneca's strategic objectives in oncology and biopharmaceuticals. The Chief Financial Officer ensures robust financial controls are in place, safeguarding company assets and supporting sustainable growth. By meticulously analyzing market trends and economic conditions, Plaza provides critical insights that inform executive decision-making. This executive ensures adherence to regulatory requirements and drives efficiency in financial processes, directly supporting AstraZeneca's mission to deliver life-changing medicines.
Santiago Rivera - Chief Financial Officer & Chief Financial Officer, Andean Cluster
Santiago Rivera, the Chief Financial Officer & Chief Financial Officer, Andean Cluster at AstraZeneca, spearheads financial operations and strategic fiscal planning for the Andean region, alongside broader financial leadership. This dual role demands meticulous management of regional financial performance, including budgeting, forecasting, and P&L responsibility, while also contributing to global financial initiatives. Rivera's oversight ensures that financial strategies are tailored to regional market dynamics, supporting AstraZeneca's commercial objectives in oncology and biopharmaceuticals. The Chief Financial Officer & Chief Financial Officer, Andean Cluster drives financial discipline and identifies opportunities for revenue enhancement and cost optimization within the specified territories. By fostering strong relationships with regional stakeholders and ensuring compliance with local financial regulations, Rivera solidifies AstraZeneca's financial standing. This executive's strategic financial acumen is crucial for expanding market access and achieving sustainable growth across the Andean cluster.
Richard Hasselbusch - Vice President and Chief Financial Officer, Global Operations and Information Technology
Richard Hasselbusch, the Vice President and Chief Financial Officer, Global Operations and Information Technology at AstraZeneca, leads financial strategy and execution for critical operational and IT functions worldwide. This executive directs the financial planning, budgeting, and analysis for global operations, ensuring efficient resource allocation and cost management. Hasselbusch's purview includes overseeing the financial aspects of information technology investments and infrastructure, aligning them with AstraZeneca's strategic goals in drug discovery and development. The Vice President and Chief Financial Officer, Global Operations and Information Technology ensures financial integrity and drives operational efficiencies through robust financial controls and performance metrics. By providing strategic financial guidance, Hasselbusch supports the seamless integration of technology and operational advancements. This leadership role is vital for optimizing the company's global operational footprint and supporting the delivery of innovative medicines.
Kevin Durning - Chief Financial Officer (US) & Vice President, Finance Biopharmaceuticals
Kevin Durning, the Chief Financial Officer (US) & Vice President, Finance Biopharmaceuticals at AstraZeneca, directs financial strategy and operations for the United States market and the Biopharmaceuticals division. This executive manages all financial planning, analysis, and reporting activities, ensuring fiscal health and strategic alignment with company objectives. Durning's responsibilities include optimizing financial performance, managing budgets, and driving revenue growth within the US biopharmaceutical sector. The Chief Financial Officer (US) & Vice President, Finance Biopharmaceuticals provides critical financial insights to support decision-making, focusing on market dynamics and investment opportunities. This leadership role ensures robust financial controls and compliance with US regulations. By guiding financial resources effectively, Kevin Durning plays a pivotal role in advancing AstraZeneca's mission to develop and deliver innovative treatments.
Joey Zhu - Chief Financial Officer, PA To The
Joey Zhu, the Chief Financial Officer, PA To The at AstraZeneca, provides critical administrative and operational support to the Chief Financial Officer, ensuring the smooth functioning of the finance department. This role involves managing schedules, coordinating meetings, and facilitating communication between the CFO and other key stakeholders across the organization. Zhu's responsibilities include preparing financial reports, organizing documentation, and assisting with the execution of financial strategies. The Chief Financial Officer, PA To The plays a vital part in maintaining organizational efficiency and supporting the strategic objectives of AstraZeneca's finance division. By ensuring seamless administrative processes, Joey Zhu enables the CFO to focus on high-level financial planning and decision-making. This support is instrumental in driving the company's financial health and its mission to deliver innovative medicines.
Jennifer Givens - Management Director, Operations & Chief Operating Officer, Oncology Research & Development
Jennifer Givens, the Management Director, Operations & Chief Operating Officer, Oncology Research & Development at AstraZeneca, orchestrates operational excellence within the Oncology Research & Development division. This executive directs the strategic planning and execution of all operational activities, ensuring seamless integration of research and development processes. Givens' leadership focuses on optimizing resource allocation, enhancing operational efficiency, and driving innovation in drug discovery and development pipelines. The Management Director, Operations & Chief Operating Officer, Oncology Research & Development ensures that R&D operations align with AstraZeneca's overarching mission to combat cancer through groundbreaking medicines. By managing complex project timelines and fostering cross-functional collaboration, Jennifer Givens accelerates the advancement of promising oncology therapies. This role is critical for translating scientific breakthroughs into tangible patient benefits.
David Auerbach - Strategy, Transformation Operations Leader & Global Chief Operating Officer, Head of Project Management Office, Oncology Research & Development
David Auerbach, the Strategy, Transformation Operations Leader & Global Chief Operating Officer, Head of Project Management Office, Oncology Research & Development at AstraZeneca, spearheads operational strategy, transformation, and project management within the Oncology R&D division. This executive directs the implementation of strategic initiatives aimed at enhancing operational efficiency and driving innovation in drug development. Auerbach's leadership focuses on optimizing the Project Management Office's functions, ensuring the successful execution of complex research and development projects. The Strategy, Transformation Operations Leader & Global Chief Operating Officer, Head of Project Management Office, Oncology Research & Development oversees the transformation of operational processes to accelerate the delivery of novel oncology therapies. By fostering a culture of continuous improvement and strategic execution, David Auerbach is instrumental in advancing AstraZeneca's commitment to fighting cancer. This role is critical for translating scientific advancements into tangible patient solutions.
Suyeon Kim - President, Country, Az (Singapore)
Suyeon Kim, the President, Country, Az (Singapore) at AstraZeneca, leads the company's operations and strategic direction within Singapore. This executive is responsible for driving business growth, ensuring market access, and overseeing all commercial activities in the region. Kim's leadership focuses on strengthening AstraZeneca's presence and impact in Singapore, aligning local operations with global objectives in oncology and biopharmaceuticals. The President, Country, Az (Singapore) fosters key relationships with healthcare providers, regulatory bodies, and local stakeholders to advance patient access to innovative medicines. By championing AstraZeneca's mission within the country, Suyeon Kim plays a crucial role in delivering life-changing treatments to patients in Singapore. This leadership position is vital for executing the company's regional strategy and achieving sustainable success.
Katharine Oteiza - Director, BPO - Biometrics Chief of Staff
Katharine Oteiza, the Director, BPO - Biometrics Chief of Staff at AstraZeneca, provides strategic support and operational leadership within the Biometrics function. This role involves coordinating key initiatives, managing cross-functional projects, and ensuring alignment with the overall Biometrics strategy. Oteiza's responsibilities include streamlining processes, enhancing communication, and driving efficiency across outsourced business operations. The Director, BPO - Biometrics Chief of Staff facilitates effective collaboration between internal teams and external partners, ensuring the timely and accurate delivery of biometric data crucial for drug development. By optimizing workflows and implementing best practices, Katharine Oteiza contributes to the integrity and speed of AstraZeneca's clinical research. This position is essential for supporting the company's commitment to delivering life-changing medicines through rigorous scientific evaluation.
Maria Sánchez - Strategic Partner & Chief of Staff
Maria Sánchez, the Strategic Partner & Chief of Staff at AstraZeneca, drives strategic initiatives and provides executive-level support to key leadership functions. This role involves facilitating cross-functional collaboration, managing critical projects, and ensuring alignment with AstraZeneca's strategic priorities in oncology and biopharmaceuticals. Sánchez's responsibilities include developing strategic plans, analyzing market opportunities, and enhancing operational effectiveness across various departments. The Strategic Partner & Chief of Staff acts as a key liaison, connecting different business units to foster synergy and drive progress towards company goals. By providing strategic counsel and operational oversight, Maria Sánchez contributes significantly to the company's mission of delivering life-changing medicines. This position is crucial for translating strategic vision into actionable outcomes.
Explore Leadership Teams in Manufacturing
Abbott is a global healthcare company that develops and delivers a broad range of medical technologies, diagnostics, nutrition products, and branded generic medicines. The company is focused on improving health outcomes and helping people live healthier lives across all stages of life. Its mission centers on creating innovative solutions that address important medical needs, including chronic disease management, cardiovascular care, diabetes care, and pain management.
Company Leadership AM
AB
JA
HS
Avara Pharmaceutical Services is a manufacturing organization. It offers aseptic liquid filling, sterile pharmaceutical, oral solid dose, packaging solutions and sterile injectables. The company was founded in 2015 and is located in Norman, Oklahoma.
Company Leadership AA
RM
RR
KB
Daewoong Pharmaceutical Co., Ltd. is a leading South Korean pharmaceutical company that develops, manufactures, and commercializes pharmaceuticals for both domestic and international markets. With its strong and competent in-house R&D and qualified manufacturing facilities (cGMP), Daewoong provides a total healthcare solution to customers across the globe. Aiming to become a global healthcare company, Daewoong has broadened international operations by establishing branch offices and research centers throughout Asia and the United States. The company was established in 1945 and is headquartered in Seoul, South Korea.
Company Leadership SP
ML
HH
NK
21st Century Vitamins operates as a globally recognized manufacturer and distributor of dietary supplements, positioned within the broader health and wellness industry. The company, through its parent entity 21st Century HealthCare, Inc., focuses on developing, producing, and delivering a wide range of vitamins, minerals, herbal supplements, and specialty nutritional products designed to support everyday health and well-being. With a history spanning more than three decades, the organization has established itself as a trusted and accessible brand in the consumer healthcare market. At its core, the company functions as both a manufacturer and a direct-to-consumer wellness provider. It produces an extensive portfolio of dietary supplements that cater to diverse health needs, including general nutrition, immune support, cardiovascular health, digestive wellness, sports nutrition, and beauty supplements. Its offerings range from traditional multivitamins and single-nutrient formulations to advanced blends such as amino acids, probiotics, and plant-based supplements. This breadth of product categories reflects the companys strategy of addressing a wide spectrum of consumer health requirements through scientifically formulated solutions.
Company Leadership SS
FC
KW
Frequently Asked Questions Regarding AstraZeneca Top Executives and Leadership Team
